These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26035122)

  • 1. Retinoic Acid Reduces Stem Cell-Like Features in Pancreatic Cancer Cells.
    Herreros-Villanueva M; Er TK; Bujanda L
    Pancreas; 2015 Aug; 44(6):918-24. PubMed ID: 26035122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
    Niess H; Camaj P; Renner A; Ischenko I; Zhao Y; Krebs S; Mysliwietz J; Jäckel C; Nelson PJ; Blum H; Jauch KW; Ellwart JW; Bruns CJ
    Target Oncol; 2015 Jun; 10(2):215-27. PubMed ID: 24950733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer.
    Zhang Y; Liu L; Fan P; Bauer N; Gladkich J; Ryschich E; Bazhin AV; Giese NA; Strobel O; Hackert T; Hinz U; Gross W; Fortunato F; Herr I
    Oncotarget; 2015 Apr; 6(12):9999-10015. PubMed ID: 25846752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype.
    Hu G; Li F; Ouyang K; Xie F; Tang X; Wang K; Han S; Jiang Z; Zhu M; Wen D; Qin X; Zhang L
    Int J Oncol; 2012 Mar; 40(3):798-806. PubMed ID: 22076649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line.
    Imaizumi A; Onishi H; Yamasaki A; Kawamoto M; Umebayashi M; Morisaki T; Hasumi K
    Anticancer Res; 2016 Feb; 36(2):653-7. PubMed ID: 26851020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a pancreatic cancer stem cell model using the SW1990 human pancreatic cancer cell line in nude mice.
    Pan Y; Gao S; Hua YQ; Liu LM
    Asian Pac J Cancer Prev; 2015; 16(2):437-42. PubMed ID: 25684468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer.
    Yabuuchi S; Pai SG; Campbell NR; de Wilde RF; De Oliveira E; Korangath P; Streppel MM; Rasheed ZA; Hidalgo M; Maitra A; Rajeshkumar NV
    Cancer Lett; 2013 Jul; 335(1):41-51. PubMed ID: 23402814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
    Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
    Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Ahmad A; Azmi AS; Sarkar SH; Banerjee S; Kong D; Li Y; Thakur S; Sarkar FH
    Cancer Prev Res (Phila); 2012 Mar; 5(3):355-64. PubMed ID: 22086681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract.
    Ottinger S; Klöppel A; Rausch V; Liu L; Kallifatidis G; Gross W; Gebhard MM; Brümmer F; Herr I
    Int J Cancer; 2012 Apr; 130(7):1671-81. PubMed ID: 21544815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer.
    Burkhart C; Fleyshman D; Kohrn R; Commane M; Garrigan J; Kurbatov V; Toshkov I; Ramachandran R; Martello L; Gurova KV
    Oncotarget; 2014 Nov; 5(22):11038-53. PubMed ID: 25402820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein.
    El-Mahdy HA; El-Husseiny AA; Kandil YI; Gamal El-Din AM
    Life Sci; 2020 Dec; 262():118518. PubMed ID: 33011221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
    Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
    Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma.
    Aboukameel A; Muqbil I; Senapedis W; Baloglu E; Landesman Y; Shacham S; Kauffman M; Philip PA; Mohammad RM; Azmi AS
    Mol Cancer Ther; 2017 Jan; 16(1):76-87. PubMed ID: 28062705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.
    Ma C; Huang T; Ding YC; Yu W; Wang Q; Meng B; Luo SX
    Int J Clin Exp Pathol; 2015; 8(6):6533-9. PubMed ID: 26261532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.
    Matsuzawa F; Kamachi H; Mizukami T; Einama T; Kawamata F; Fujii Y; Fukai M; Kobayashi N; Hatanaka Y; Taketomi A
    BMC Cancer; 2021 Feb; 21(1):200. PubMed ID: 33637083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells.
    Vaz AP; Ponnusamy MP; Rachagani S; Dey P; Ganti AK; Batra SK
    Br J Cancer; 2014 Jul; 111(3):486-96. PubMed ID: 25003666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
    Bader Y; Hartmann J; Horvath Z; Saiko P; Grusch M; Madlener S; Maier S; Oehler L; Fritzer-Szekeres M; Heller N; Alken RG; Krupitza G; Szekeres T
    Cancer Lett; 2008 Feb; 259(2):231-9. PubMed ID: 18023527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
    Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y
    Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.